Inhibition of Leishmania mexicana Growth by the Tuberculosis Drug SQ109.

Authors :: García-García V
Oldfield E
Benaim G
Source :: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2016 Sep 23; Vol. 60 (10), pp. 6386-9. Date of Electronic Publication: 2016 Sep 23 (Print Publication: 2016).
Publication Year :: 2016
Abstract: We report that the tuberculosis drug SQ109 [N-adamantan-2-yl-N'-((E)-3,7-dimethyl-octa-2,6-dienyl)-ethane-1,2-diamine] has potent activity against the intracellular amastigote form of Leishmania mexicana (50% inhibitory concentration [IC50], ∼11 nM), with a good selectivity index (>500). It is also active against promastigotes (IC50, ∼500 nM) and acts as a protonophore uncoupler, in addition to disrupting Ca(2+) homeostasis by releasing organelle Ca(2+) into the cytoplasm, and as such, it is an interesting new leishmaniasis drug hit candidate.<br /> (Copyright © 2016, American Society for Microbiology. All Rights Reserved.)